Market Overview

Meridian Bioscience Inc. (NASDAQ: VIVO)

9.87 +0.05 (0.51%)

Earnings

QuarterPriorEstimateActualSurprise
Q3 2020
Pre-Market
EPS:
REV:




Q2 2020
Pre-Market
EPS:
REV:
0.19
50.248M



Q1 2020
Pre-Market
EPS:
REV:
0.2
51.48M



Q4 2019
Pre-Market
EPS:
REV:
0.2
53.1M



Q3 2019
Pre-Market
EPS:
REV:
0.18
51.737M
0.09
49.81M
0.16
48.44M
77.78%
-2.75%
Q2 2019
Pre-Market
EPS:
REV:
0.21
56.451M
0.16
51.74M
0.19
50.248M
18.75%
-2.88%
Q1 2019
Pre-Market
EPS:
REV:
0.15
52.283M
0.18
53.68M
0.2
51.48M
11.11%
-4.1%
Q4 2018
Pre-Market
EPS:
REV:

0.16
51.11M
0.2
53.1M
25%
3.89%
Q3 2018
Pre-Market
EPS:
REV:
0.16
50.14M
0.23
52.12M
0.18
51.737M
-21.74%
-0.73%
Q2 2018
Pre-Market
EPS:
REV:
0.22
54.125M
0.25
3.29B
0.21
56.451M
-16%
-98.28%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!